Apixaban vs. Warfarin in Atrial Fibrillation Patients With Chronic Kidney Disease

Background and Objectives: Real-world evidence of apixaban treatment in patients with chronic kidney disease remains scarce. This study aimed to compare the relative risk of stroke or systemic embolism (SE) and major bleeding between apixaban and warfarin in atrial fibrillation (AF) patients with di...

Descripció completa

Dades bibliogràfiques

Autors principals:	Chung-Ming Fu, Lung-Chih Li, Yueh-Ting Lee, Shih-Wei Wang, Chien-Ning Hsu
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2021-10-01
Col·lecció:	Frontiers in Cardiovascular Medicine
Matèries:	apixaban warfarin chronic kidney disease atrial fibrillation (AF) ischemic stroke bleeding
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fcvm.2021.752468/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!